Dr. Alexander Chernobelsky, MD
What this data tells you about Dr. Chernobelsky
Dr. Alexander Chernobelsky is a cardiovascular disease in Wellington, FL, with 19 years in practice. Based on federal Medicare data, Dr. Chernobelsky performed 4,517 Medicare services across 2,866 unique beneficiaries.
Between the years covered by Open Payments, Dr. Chernobelsky received a total of $60,686 from 31 pharmaceutical and/or device companies across 768 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Chernobelsky is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| EKG interpretation and report | 962 | $7 | $32 |
| Office visit, established patient (30-39 min) | 644 | $94 | $267 |
| Hospital follow-up visit, high complexity | 514 | $95 | $220 |
| Electrocardiogram (EKG), 12-lead | 446 | $11 | $36 |
| Regadenoson injection (Lexiscan) for heart stress test | 232 | $44 | $111 |
| Echocardiogram, transthoracic | 209 | $146 | $427 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 206 | $28 | $74 |
| Initial hospital admission, high complexity | 180 | $140 | $429 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 156 | $174 | $225 |
| Remote pacemaker/defibrillator monitoring, 90 days | 129 | $17 | $54 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 124 | $20 | $57 |
| Hospital follow-up visit, moderate complexity | 102 | $65 | $155 |
| New patient office visit (45-59 min) | 101 | $124 | $354 |
| Remote pacemaker monitoring, 90 days | 93 | $23 | $66 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 83 | $20 | $56 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 79 | $49 | $148 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 78 | $343 | $1,017 |
| Mri scan of blood flow of heart | 43 | $10 | $26 |
| Mri scan of heart before and after contrast | 42 | $99 | $270 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 36 | $27 | $95 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 22 | $21 | $56 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 22 | $668 | $1,459 |
| Ultrasound of heart, follow-up | 14 | $20 | $54 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
The majority of payments (82%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 7% for cardiovascular disease in FL.
Geographic Context
5.8 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Chernobelsky is a clinical cardiology specialist, with above-average Medicare volume (top 24% in FL), and high industry engagement (consulting-driven, top 7%), with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Chernobelsky experienced with ekg interpretation and report?
Does Dr. Chernobelsky receive payments from pharmaceutical companies?
How do Dr. Chernobelsky's costs compare to other cardiovascular diseases in Wellington?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology